Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07430670 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Theravex Oral and Theravex Tissue Care Plus in the Healing Process of Mucogingival Surgery

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This clinical study assesses the efficacy of two novel bioactive solutions, Theravex Oral and Theravex Tissue Care Plus, in enhancing soft tissue healing after periodontal surgery. The study focuses on patients undergoing a Modified Free Gingival Graft (M-FGG) technique to treat gingival recessions around mandibular incisors. Participants are randomly assigned to a test group receiving the Theravex treatment or a control group receiving a saline placebo. The primary goal is to measure the impact of these solutions on root coverage and other key outcomes, such as tissue gain, color integration, and postoperative pain, over a one-year period.
Trial Details
NCT Number NCT07430670
Lead Sponsor Universidad Complutense de Madrid
Collaborators: Biointelligent Technology Systems SL
Conditions
(from sponsor)		 Gingival Recession, Localized
Related terms Gingival Recession, Neovascularization, Pathologic
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov